Yang F, Liu G, Mao F, Zheng YC, et al. Corrigendum to "Re: Pathologic complete responses, long-term outcomes, and recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy in breast cancer" Eur J Cancer 2024 Feb 2:113559. doi: 10.1016/j.ejca.2024.113559.
PMID: 38310078